Authors: Van Dalen, A Favier, J Baumgartner, L Hasholzner, U De Bruijn, H Dobbler, D Dombi, VH Fink, D Giai, M Mcging, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Bowman, A Einarsson, R

Citation: A. Van Dalen et al., Serum levels of CA 125 and TPS during treatment of ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5107-5108

Authors: van Dalen, A Favier, J Burges, A Hasholzner, U de Bruijn, HWA Dobler-Girdziunaite, D Dombi, VH Fink, D Giai, M McGing, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Bowman, A Einarsson, R

Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients, GYNECOL ONC, 79(3), 2000, pp. 444-450

Authors: Van Dalen, A Favier, J Baumgartner, L Hasholzner, U De Bruijn, H Dobbler, D Dombi, VH Fink, D Giai, M McGing, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Einarsson, R

Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients, ANTICANC R, 19(4A), 1999, pp. 2523-2526